New York State Common Retirement Fund Bei Gene, Ltd. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Bei Gene, Ltd. stock. As of the latest transaction made, New York State Common Retirement Fund holds 8,569 shares of BGNE stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,569

Previous 8,569 -0.0%

Holding current value

$1.66 Million

Previous $1.22 Million 57.32%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$129.52 - $174.32 $342,968 - $461,599	2,648 Added 44.72%	8,569 $1.22 Million
Q1 2024 May 07, 2024	BUY	$141.8 - $181.47 $839,597 - $1.07 Million	5,921 New	5,921 $926,000
Q2 2022 Aug 04, 2022	SELL	$121.11 - $216.05 $7.98 Million - $14.2 Million	-65,860 Reduced 99.58%	275 $45,000
Q1 2022 May 05, 2022	SELL	$146.52 - $269.56 $5.49 Million - $10.1 Million	-37,475 Reduced 36.17%	66,135 $12.5 Million
Q4 2021 Feb 02, 2022	SELL	$248.56 - $389.34 $2.94 Million - $4.6 Million	-11,826 Reduced 10.24%	103,610 $28.1 Million
Q2 2021 Aug 02, 2021	BUY	$292.75 - $367.01 $80,506 - $100,927	275 Added 0.24%	115,436 $39.6 Million
Q1 2021 May 11, 2021	BUY	$260.64 - $382.12 $20.2 Million - $29.7 Million	77,686 Added 207.3%	115,161 $40.1 Million
Q4 2020 Feb 08, 2021	SELL	$221.31 - $316.61 $11.3 Million - $16.1 Million	-50,943 Reduced 57.62%	37,475 $9.68 Million
Q2 2020 Aug 07, 2020	BUY	$123.9 - $195.41 $1.55 Million - $2.44 Million	12,485 Added 16.44%	88,418 $16.7 Million
Q1 2020 May 06, 2020	BUY	$121.84 - $173.19 $1.09 Million - $1.55 Million	8,958 Added 13.38%	75,933 $9.35 Million
Q4 2019 Feb 05, 2020	SELL	$115.78 - $208.34 $370,496 - $666,688	-3,200 Reduced 4.56%	66,975 $11.1 Million
Q3 2019 Nov 07, 2019	SELL	$120.61 - $148.29 $1.69 Million - $2.08 Million	-14,024 Reduced 16.66%	70,175 $8.59 Million
Q2 2019 Aug 09, 2019	BUY	$113.99 - $146.86 $21,202 - $27,315	186 Added 0.22%	84,199 $10.4 Million
Q1 2019 May 08, 2019	BUY	$122.82 - $151.83 $4.02 Million - $4.96 Million	32,700 Added 63.73%	84,013 $11.1 Million
Q4 2018 Feb 08, 2019	BUY	$107.01 - $175.15 $5.49 Million - $8.99 Million	51,313 New	51,313 $7.2 Million

Others Institutions Holding BGNE

# of Institutions

244

Shares Held

45.3M

Call Options Held

258K

Put Options Held

52.2K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $20B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Bei Gene, Ltd. Transaction History